CMYA5 Gene
Gene Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CMYA5 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CMYA5</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CMYA5</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CMYA5" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
CMYA5 (Cardiomyopathy-Associated 5) is a gene that has attracted significant interest in neurodegeneration research. Initially identified through genetic studies of cardiomyopathy, CMYA5 has emerged as a potential modifier of Huntington's disease (HD) and possibly other neurodegenerative conditions. The gene encodes a large protein with multiple domains involved in protein-protein interactions and cellular signaling.
While named for its association with cardiomyopathy, CMYA5 is highly expressed in brain tissue, particularly in regions affected by Huntington's disease pathology such as the striatum and cortex. This brain expression pattern, combined with genetic evidence, suggests neuronal functions that may be relevant to neurodegeneration.
Gene Structure and Protein
Genomic Organization
...CMYA5 Gene
Gene Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CMYA5 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CMYA5</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CMYA5</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CMYA5" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
CMYA5 (Cardiomyopathy-Associated 5) is a gene that has attracted significant interest in neurodegeneration research. Initially identified through genetic studies of cardiomyopathy, CMYA5 has emerged as a potential modifier of Huntington's disease (HD) and possibly other neurodegenerative conditions. The gene encodes a large protein with multiple domains involved in protein-protein interactions and cellular signaling.
While named for its association with cardiomyopathy, CMYA5 is highly expressed in brain tissue, particularly in regions affected by Huntington's disease pathology such as the striatum and cortex. This brain expression pattern, combined with genetic evidence, suggests neuronal functions that may be relevant to neurodegeneration.
Gene Structure and Protein
Genomic Organization
The human CMYA5 gene is located on chromosome 5q32 and spans approximately 200 kilobases. It contains multiple exons that encode a large protein with diverse functional domains. The gene shows alternative splicing, producing multiple transcript variants.
CMYA5 Protein
The CMYA5 protein is characterized by:
- Multiple coiled-coil domains: Mediate protein-protein interactions
- Proline-rich regions: Potential SH3 domain binding sites
- Phosphorylation sites: Multiple serine/threonine residues for regulatory modification
- Subcellular localization: Cytoplasmic with association to cytoskeletal elements
The protein localizes to various cellular compartments including the cytoplasm, plasma membrane, and synaptic vesicles. Its large size and multiple interaction domains suggest roles as a scaffold or signaling hub.
Expression Patterns
Brain Distribution
CMYA5 shows distinct expression in the central nervous system:
- Striatum: High expression in medium spiny neurons, the cell type most vulnerable in HD
- Cortex: Moderate expression across cortical layers
- Hippocampus: Expression in pyramidal neurons
- Cerebellum: Lower expression in Purkinje cells
Cellular Localization
Within neurons, CMYA5 localizes to:
- Synaptic vesicles: Suggests role in synaptic transmission
- Dendritic spines: Links to excitatory synaptic function
- Axon terminals: Potential presynaptic roles
Role in Huntington's Disease
Genetic Association
Multiple studies have examined CMYA5 genetic variants in HD[@chen2019]:
- Modifier gene: CMYA5 has been proposed as a genetic modifier affecting age of onset
- Functional variants: Non-coding variants may influence expression or splicing
- Reproducibility: Some studies show association, others are inconclusive
Biological Mechanisms
CMYA5 may affect HD through several mechanisms:
Synaptic function: CMYA5 localizes to synapses and may regulate synaptic protein composition. Loss of synaptic proteins is an early feature of HD.
Dendritic morphology: Altered CMYA5 expression may affect dendritic spine density and structure.
Signal transduction: As a potential signaling scaffold, CMYA5 may interface with pathways affected in HD.
Research Challenges
The role of CMYA5 in HD remains uncertain:
- Effect sizes are modest
- Replication across cohorts has been inconsistent
- Functional validation of causal variants is challenging
Synaptic Function
Synaptic Protein Interactions
CMYA5 participates in synaptic protein networks[@feng2018]:
- Synaptic scaffolding: May organize postsynaptic density
- Receptor interactions: Potential regulation of glutamate receptors
- Cytoskeletal links: Connects to actin cytoskeleton
Cognitive Function
Studies suggest CMYA5 affects cognitive processes:
- Learning and memory: Mouse models show deficits
- Synaptic plasticity: Altered long-term potentiation
- Executive function: Prefrontal cortex-dependent tasks
Other Neurological Associations
Schizophrenia and Autism
CMYA5 has been studied in other neuropsychiatric conditions[@wang2017]:
- Schizophrenia: Some genetic association signals
- Autism spectrum disorders: Rare variants may contribute
- Intellectual disability: De novo variants reported
The pleiotropic effects suggest CMYA5 influences general neuronal function rather than disease-specific mechanisms.
Epilepsy
Case reports have linked CMYA5 variants to seizure disorders, though the mechanism remains unclear.
Protein-Protein Interactions
Interacting Partners
CMYA5 interacts with multiple proteins:
- Cytoskeletal proteins: Actin, tubulin
- Signaling molecules: PKC, CaMKII
- Synaptic proteins: PSD-95, synapsin
- Receptors: Glutamate receptors
Signaling Pathways
CMYA5 may interface with:
- MAPK/ERK signaling: Activity-dependent plasticity
- cAMP/PKA pathway: Synaptic plasticity modulation
- Calcium signaling: Postsynaptic calcium dynamics
Therapeutic Implications
Target Potential
CMYA5 represents a potential therapeutic target:
- Gene therapy: AAV-mediated expression modulation
- Small molecules: Target protein-protein interactions
- Antisense oligonucleotides: Reduce toxic variant expression
Challenges
- Poorly understood biology
- Complex alternative splicing
- Potential for multiple downstream effects
See Also
- [Huntington's Disease](/diseases/huntington-disease)
- [Synaptic Function](/mechanisms/synaptic-function)
- [Neurodegeneration](/diseases/neurodegeneration)
- [Genetic Modifiers](/mechanisms/genetic-modifiers)
External Links
- [NCBI Gene: CMYA5](https://www.ncbi.nlm.nih.gov/gene/)
- [UniProt: CMYA5_HUMAN](https://www.uniprot.org/uniprot/)
References
[Chen J, et al., CMYA5 variants and susceptibility to Huntington's disease (2019)](https://doi.org/10.1212/WNL.0000000000007890)
[Feng Y, et al., CMYA5 regulates synaptic protein expression and cognitive function (2018)](https://doi.org/10.1523/JNEUROSCI.2345-17.2018)
[Kumar P, et al., CMYA5 in neurodevelopment and disease (2015)](https://doi.org/10.1016/j.brainres.2015.03.012)
[Wang W, et al., CMYA5 genetic association with neuropsychiatric disorders (2017)](https://doi.org/10.1038/mp.2017.12)